YAP1 and non-small cell lung carcinoma: It has been suggested by previous studies that ERK1-2 (extracellular signal–regulated kinases) inhibition participates in reducing the YAP protein level, which in turn down-regulates expression of the downstream genes of the Hippo pathway to suppress migration and invasion of NSCLC cells [46].